NASDAQ · Medical - Pharmaceuticals

Circle8 Group, Inc. (CIRC) Stock

$0.45 -3.04% NASDAQ: CIRC Healthcare

Valuation

MetricValue
Price$0.45
Market Cap$40.12M
P/E Ratio-0.21
P/B Ratio0.59
P/S Ratio0.04
EPS (TTM)$-1.08
52-Week High$4.56
52-Week Low$0.31
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-389.99%
ROA-15.81%
ROCE-43.08%
Gross Margin-11.47%
Operating Margin-11.47%
Net Margin-19.39%
Debt/Equity10.24
Current Ratio0.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$401.0M$443.0M$436.0M
Operating Profit$-3.0M$-4.0M$-3.0M$-22.0M$-50.0M
Net Profit$-4.0M$-4.0M$-15.0M$-135.0M$-59.0M
EPS$-0.51$-12.38$-0.60$-3.68$-1.08
Op Margin-1214.0%-5082.0%-1.0%-5.0%-12.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$11.0M$8.0M$127.0M$120.0M$113.0M
Total Liabilities$3.0M$4.0M$166.0M$132.0M$145.0M
Cash$4.0M$2.0M$1.0M$1.0M$0
Borrowings——$139.0M$81.0M$85.0M

Latest News

Circle8 Awarded Two $20 Million Dutch Public Sector Contract Extensions, Demonstrating Positive Commercial Momentum Across the Public Sector GlobeNewswire · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-4.0M$-9.0M$-6.0M$-4.0M
Investing Cash Flow$-6.0M$2.0M$0$0$0
Financing Cash Flow$12.0M—$9.0M$5.0M$4.0M
Net Cash Flow$4.0M$-2.0M$0$-1.0M$-1.0M
Free Cash Flow$-2.0M$-4.0M$-9.0M$-6.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-8.02
FCF Yield-63.05%
Quick Ratio0.39
Interest Coverage-6.63
Return 1Y-60.71%
Return 3Y-95.45%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About Circle8 Group, Inc.

Circle8 Group, Inc. is headquartered in US.

Circle8 Group, Inc. (CIRC) stock trades at $0.45 with a market capitalization of $40.12M. The stock is valued at a price-to-earnings (P/E) ratio of -0.21, price-to-book of 0.59, price-to-sales of 0.04. Over the past 52 weeks the stock has ranged between $0.31 and $4.56, and currently trades 90.1% below its 52-week high.

On profitability, Circle8 Group, Inc. generates a return on equity (ROE) of -389.99%, return on capital employed of -43.08%, an operating margin of -11.47%, a net profit margin of -19.39%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides